CSL Ltd
OTC:CSLLY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CSL Ltd
OTC:CSLLY
|
AU |
|
Darma Henwa Tbk PT
F:0DH
|
ID |
|
KBC Groep NV
XBRU:KBC
|
BE |
|
Y
|
Yamaha Motor Co Ltd
SWB:YMA
|
JP |
|
Lunai Bioworks Inc
NASDAQ:LNAI
|
US |
|
D
|
DSM-Firmenich AG
AEX:DSFIR
|
CH |
|
F
|
Fairfax Financial Holdings Ltd
XMUN:FFX
|
CA |
|
Silex Systems Ltd
ASX:SLX
|
AU |
|
A
|
Avacta Group PLC
F:RTQ1
|
UK |
|
Kroger Co
NYSE:KR
|
US |
|
Tata Motors Passenger Vehicles Ltd
NSE:TMPV
|
IN |
|
Inseego Corp
NASDAQ:INSG
|
US |
|
DP Eurasia NV
LSE:DPEU
|
NL |
|
MSCI Inc
NYSE:MSCI
|
US |
|
C
|
Carrefour SA
OTC:CRERF
|
FR |
|
Kinarus Therapeutics Holding AG
SIX:KNRS
|
CH |
|
United Microelectronics Corp
TWSE:2303
|
TW |
|
SiTime Corp
NASDAQ:SITM
|
US |
|
N
|
Netflix Inc
MIL:NFLX
|
US |
|
D
|
Draganfly Inc
NASDAQ:DPRO
|
CA |
|
N
|
Nordic American Tanker Ltd
XBER:B3O
|
BM |
|
Shift Inc
TSE:3697
|
JP |
Bankruptcy Probability
CSL Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
CSL Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
CSL Ltd
ASX:CSL
|
51.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
191.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
149.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
116.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Baxter International Inc
NYSE:BAX
|
10.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
402.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
156B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
64.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
CSL Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, CSL Ltd has total debt of 10.6B USD. This includes both short-term (165m USD) and long-term (10.4B USD) debt.
You can find a full breakdown on its Balance Sheet.
